146 related articles for article (PubMed ID: 1905553)
21. Transient elevation of serum HIV antigen levels associated with intercurrent infection.
Claydon EJ; Bennett J; Gor D; Forster SM
AIDS; 1991 Jan; 5(1):113-4. PubMed ID: 1905552
[No Abstract] [Full Text] [Related]
22. Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection.
Henrard DR; Wu S; Phillips J; Wiesner D; Phair J
J Clin Microbiol; 1995 Jan; 33(1):72-5. PubMed ID: 7699069
[TBL] [Abstract][Full Text] [Related]
23. Actuarial rate of clinical and biological progression in a cohort of 250 HIV-1-seropositive subjects. Laennec HIV Study Group.
Venet A; Tourani JM; Beldjord K; Eme D; Even P; Andrieu JM
Clin Exp Immunol; 1990 May; 80(2):151-5. PubMed ID: 1972669
[TBL] [Abstract][Full Text] [Related]
24. CD4 lymphocyte counts and serum p24 antigen of no diagnostic value in monitoring HIV-infected patients with pulmonary symptoms.
Orholm M; Nielsen TL; Nielsen JO; Lundgren JD
AIDS; 1990 Feb; 4(2):163-6. PubMed ID: 1970256
[TBL] [Abstract][Full Text] [Related]
25. [ Biological criteria for prediction of the clinical course leading to AIDS].
Salmon D; Couroucé AM; Doinel C; Fine JM; Kaplan C; Lambin P; Lefrère JJ; Rouger P; Salmon C
Rev Fr Transfus Hemobiol; 1990 Dec; 33(6):407-14. PubMed ID: 1981002
[No Abstract] [Full Text] [Related]
26. Risk factors for progression of human immunodeficiency virus (HIV) infection among seroconverted and seropositive homosexual men.
van Griensven GJ; de Vroome EM; de Wolf F; Goudsmit J; Roos M; Coutinho RA
Am J Epidemiol; 1990 Aug; 132(2):203-10. PubMed ID: 1973594
[TBL] [Abstract][Full Text] [Related]
27. Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection.
Rinaldo C; Kingsley L; Neumann J; Reed D; Gupta P; Lyter D
J Clin Microbiol; 1989 May; 27(5):880-4. PubMed ID: 2501352
[TBL] [Abstract][Full Text] [Related]
28. Lack of HPA-23 antiviral activity in HIV-infected patients without AIDS.
Burgard M; Sansonetti P; Vittecoq D; Descamps P; Guetard D; Herson S; Rozenbaum W; Rouzioux C
AIDS; 1989 Oct; 3(10):665-8. PubMed ID: 2480798
[TBL] [Abstract][Full Text] [Related]
29. Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count.
Eyster ME; Ballard JO; Gail MH; Drummond JE; Goedert JJ
Ann Intern Med; 1989 Jun; 110(12):963-9. PubMed ID: 2567142
[TBL] [Abstract][Full Text] [Related]
30. Quantitation of human immunodeficiency virus in vertically infected infants and children.
Alimenti A; Luzuriaga K; Stechenberg B; Sullivan JL
J Pediatr; 1991 Aug; 119(2):225-9. PubMed ID: 1677684
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 seropositivity and mortality at University Hospital, Kinshasa, Zaire, 1987.
Nelson AM; Hassig SE; Kayembe M; Okonda L; Mulanga K; Brown C; Kayembe K; Kalengayi MM; Mullick FG
AIDS; 1991 May; 5(5):583-6. PubMed ID: 1907462
[TBL] [Abstract][Full Text] [Related]
32. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.
Farzadegan H; Henrard DR; Kleeberger CA; Schrager L; Kirby AJ; Saah AJ; Rinaldo CR; O'Gorman M; Detels R; Taylor E; Phair JP; Margolick JB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):448-55. PubMed ID: 8970472
[TBL] [Abstract][Full Text] [Related]
33. False-positive HIV-1 p24 antigenemia with unusual pattern of neutralization.
Barbouche RM; Bürgisser P; Slim A; Largueche B; Dellagi K
Arch Inst Pasteur Tunis; 1999; 76(1-4):11-2. PubMed ID: 14666751
[No Abstract] [Full Text] [Related]
34. Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells.
Puddu P; Locardi C; Sestili P; Varano F; Petrini C; Modesti A; Masuelli L; Gresser I; Belardelli F
J Virol; 1991 May; 65(5):2245-53. PubMed ID: 1901915
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of three enzyme immunoassays for HIV-1 antigen detection.
Willoughby PB; Lisker A; Folds JD
Diagn Microbiol Infect Dis; 1989; 12(4):319-26. PubMed ID: 2512047
[TBL] [Abstract][Full Text] [Related]
36. Screening of selected male blood donors for p24 antigen of human immunodeficiency virus type 1. The Transfusion Safety Study Group.
Busch MP; Taylor PE; Lenes BA; Kleinman SH; Stuart M; Stevens CE; Tomasulo PA; Allain JP; Hollingsworth CG; Mosley JW
N Engl J Med; 1990 Nov; 323(19):1308-12. PubMed ID: 2120588
[TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.
Sundqvist VA; Albert J; Ohlsson E; Hinkula J; Fenyö EM; Wahren B
J Med Virol; 1989 Nov; 29(3):170-5. PubMed ID: 2482339
[TBL] [Abstract][Full Text] [Related]
38. Discriminating between protective and enhancing HIV antibodies.
Bernard J; Reveil B; Najman I; Liautaud-Roger F; Fouchard M; Picard O; Cattan A; Mabondzo A; Laverne S; Gallo RC
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):243-9. PubMed ID: 2109624
[TBL] [Abstract][Full Text] [Related]
39. Relationship of circulating CD4+ T-lymphocytes and p24 antigenemia to the risk of developing AIDS in HIV-infected subjects with oral hairy leukoplakia.
Ravina A; Ficarra G; Chiodo M; Mazzetti M; Romagnani S
J Oral Pathol Med; 1996 Mar; 25(3):108-11. PubMed ID: 9148036
[TBL] [Abstract][Full Text] [Related]
40. Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gag.
Marcus-Sekura CJ; Woerner AM; Klutch M; Quinnan GV
Biochim Biophys Acta; 1988 Feb; 949(2):213-23. PubMed ID: 2449245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
